Mirum Pharmaceuticals, Inc.MIRMNASDAQ
Loading
Debt to Assets Over TimeElevated
Percentile Rank71
3Y CAGR+293.9%
5Y CAGR+94.7%
Studio
Year-over-Year Change

Debt-to-assets ratio

3Y CAGR
+293.9%/yr
Annual compound
5Y CAGR
+94.7%/yr
Recent acceleration
Percentile
P71
Within normal range
vs 5Y Ago
28x
Strong expansion
Streak
2 yr
Consecutive declineElevated
PeriodValueYoY Change
20250.38-20.0%
20240.47-0.6%
20230.48+7586.2%
20220.01-30.1%
20210.01-34.5%
20200.01-45.5%
20190.02-
20180.00-